期刊文献+

氯烯雌酚醚联合防风通圣散对银屑病患者CRP、IL-2、IL-4、IL-10及IL-12影响研究 被引量:1

Study on Chlorotrianisene Combination of Fangfeng Tongsheng Powder in Patients with Psoriasis of CRP IL-2 IL-4 IL-12 and IL-10
下载PDF
导出
摘要 目的:探讨氯烯雌酚醚联合防风通圣散对银屑病患者CRP、IL-2、IL-4、IL-10及IL-12影响。方法:选取我院皮肤科收治的稳定期银屑病患者92例,采用随机数字表方法将所有患者平均分为两组,各组46例,对照组予以阿维A胶囊、醋酸泼尼松龙片、甲氨蝶呤片等常规治疗,治疗组在对照组常规治疗的基础上加用氯烯雌酚醚4 mg,防风通圣散3 g,日3次口服。分别检测两组患者治疗前后血清中CRP、IL-2、IL-4、IL-10及IL-12水平,根据患者治疗前后皮损程度及病情状况采用PASI评分法判定治疗效果。结果:1与治疗前相比,两组患者治疗后CRP、IL-2及IL-12水平明显降低,而IL-4、IL-10水平明显升高(P<0.05);2治疗后与对照组相比,治疗组血清中CRP、IL-2及IL-12水平明显降低,而IL-4、IL-10水平明显升高(P<0.05);3治疗组治疗后临床总有效率(93.48%)明显高于对照组临床总有效率(78.26%)(P<0.05)。结论:氯烯雌酚醚联合防风通圣散能够降低银屑病患者血清中CRP、IL-2及IL-12水平,提高IL-4、IL-10水平,改善皮损程度,提高临床治疗疗效,对临床具有重要的临床应用价值。 Objective:To investigate the chlorotrianisene combination of Fangfeng Tongsheng Powder in patients with psoriasis of CRP,IL-2,IL-4,IL-12 and IL-10. Methods:92 patients with psoriasis from our hospital were selected and divided into control group and experiment group by Using random number table method.Control group were treated by Acitretin Capsules,Prednisolone Acetate Tablets,Methotrexate Tablets and other conventional treatment.Experiment group were treated on the base of control group with chlorotrianisene 4 mg,Fangfeng Tongsheng Powder 3 g. Serum levels of CRP,IL-2,IL-4,IL-10 and IL-12 were compared before and after treatment.According to the patients before and after treatment in patients with skin lesions and disease status using PASI score method to determine the treatment effect. Results:Compared with before treatment,CRP,IL-2 and IL-12 levels were lower(P〈0.05),IL-10,IL-4 level were higher(P〈0.05). Compared with control group after treatment,Serum levels of IL-12,IL-2 and CRP were lower(P〈0.05),IL-10,IL-4 level were higher(P〈0.05).The total effective rate of treatment group(93.48%)was significantly higher than that of the control group(78.26%)(P〈0.05). Conclusion:Chlorotrianisene joint Fangfeng Tongsheng scattered in sera of patients with psoriasis CRP,IL-2 and IL-12 levels can be reduced,to improve the level of IL-4 and IL-10,improve the degree of skin lesions,improve the clinical efficacy,the clinical has important value in clinical application.
机构地区 安康市中心医院
出处 《辽宁中医药大学学报》 CAS 2015年第10期158-160,共3页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 氯烯雌酚醚 防风通圣散 银屑病 C反应蛋白 白介素 临床疗效 Chlorotrianisene Fangfeng Tongsheng Powder psoriasis C reactive protein interleukin clinical effect
  • 相关文献

参考文献7

  • 1刘学伟.试论血与银屑病病因病机的相关性[J].中医研究,2010,23(4):10-12. 被引量:6
  • 2武红艳,郭娟宁,樊爱英,邢雪琨.肿瘤病死因子α与β基因多态性与寻常性银屑病的相关性研究[J].临床皮肤科杂志,2012,41(11):658-660. 被引量:4
  • 3Plaques P, Gottlieb A B, Chamian F, et al. TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques[ J ] .Journal of Immunology, 2013,175 ( 4 ) : 2721-2729.
  • 4Parisi R, Symmons D P, Griffiths C E. Global epidemiology of psoriasis : a systematic review of incidence and prevalence[ J ] . Journal of Investigative Dermatology, 2013,133 ( 2 ) : 377-385.
  • 5Gordon K B, Gottlieb A B, Leonardi C L, et al. Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy[ J ] .Journal of Dermatological Treatment, 2015,17( 1):9-17.
  • 6Dyken S J V. Interleukin-4- and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and Disease[ J ] .Annual Review of Immunology,2013,31 ( 5 ): 317-343.
  • 7Kirchberger S, Royston D J, Boulard O, et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model[ J ] .Journal of Experimental Medicine, 2013, 210 ( 5 ): 917-931.

二级参考文献15

  • 1张安平,周澜,杨森,张学军.皖籍汉族人寻常型银屑病患者TNF-α基因多态性分析[J].疾病控制杂志,2004,8(5):421-424. 被引量:5
  • 2龙福泉,李学平,邓丹琪,周晓鸿,冒长峙.寻常性银屑病患者肿瘤坏死因子α基因启动子多态性的检测[J].中华皮肤科杂志,2005,38(3):172-173. 被引量:3
  • 3AI Robaee AA. Molecular genetics of Psoriasis (Principles, technology, gene location, genetic polymor phism and gene expression)[J]. Int J Health Sci, 2010,4(2): 103-127.
  • 4Kim TG, Pyo CW, Hur SS, et al. Polymorphisms of tumor necrosis faetor (TNF) α and β genes in Korean patients with psoriasis[J]. Arch Dermatol Res, 2003, 295(1): 8-13.
  • 5Magalhaes RF, Biral AC, Pancoto JA, et al. Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study.International Journal of Dermatology[J]. Int J Dermatol, 2010, 49(10): 1133-1140.
  • 6Nedoszytko B, Szczerkowska DA, Zablotna M, et al. Associations of promoter region polymorphisms in the turnout necrosis factor alpha gene and early-onset psoriasis vulgaris in a northern Polish population[J]. Br J Dermatol, 2007, 157(1): 165-167.
  • 7Ramasawmy R, Fae KC, Spina G, et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-α with clinical outcomes of rheumatic fever [J]. Mol Immunol, 2007, 44(8): 1873-1878.
  • 8Arias AI, Giles B, Eiermann TH, et al. tumor necrosis factoralpha gene polymorphism in psoriasis[J]. Exp Clin Immunogenet,1997, 14(2): 118-122.
  • 9Reich K, Mossner R, Konig IR, et al. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin beta are associated with different subtypes of psoriasis character ized by early and late disease onset[J]. J Invest Dermatol, 2002, 118(1): 155-163.
  • 10Hohler T, Grossmann S, Stradmann B, et al. Differential association of polymorphisms in the TNF-alpha region with psoriatic arthritis but not psoriasis[J]. Ann Rheum Dis, 2002, 61(3): 13-218.

共引文献8

同被引文献20

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部